Category: HIV-AIDS

Chapel Hill, NC — A new comprehensive scoping review led by researchers at the UNC Institute for Global Health and Infectious Diseases finds definitions of “persistence” in HIV pre‑exposure prophylaxis (PrEP) research vary widely across studies, making it difficult to compare outcomes, evaluate interventions, and inform public health decision‑making. If...

Lauryn Ursery is a PhD student in epidemiology studying at the Gillings School of Global Public Health, mentored by Dr. Ross Boyce. In rural Western Uganda, people living with HIV face unique health risks, including viral acute respiratory infections (ARIs) such as the flu. Ursery presented a study led by...

Dr. Myron Cohen, who has been an infectious disease researcher and administrator at UNC Chapel Hill for more than four decades, was lauded worldwide in 2011 for leading a seminal study showing a stunning result:  Treating people with HIV with antiretroviral drugs could keep them from passing along human immunodeficiency...

Edward P. Browne, PhD, conducted a review that outlines current model systems of HIV latency and their analysis with single-cell omics technologies. Several recent papers have applied cutting-edge single-cell omics methods to model systems of HIV latency. Single-cell technologies provide sensitive detection of cellular subpopulations that contribute to proviral reactivation...

Researchers at the UNC School of Medicine’s International Center for the Advancement of Translational Science and the Institute for Global Health and Infectious Diseases have developed a new approach for the detailed evaluation of HIV infection throughout the entire male genital tract, HIV acquisition via the penis and the efficient...

HIV virus eradication is a complex health challenge due to its long-lived persistence and how it hides in latently infected cells that escape the body’s immune system. Effective HIV treatments have decreased the likelihood of someone developing AIDS, while helping individuals live long and healthy lives without transmission to sexual...

Almost 40 years after the discovery of HIV, a new NOVA program “Ending HIV in America” reflects on the history of one of the most elusive and deadly viruses to ever infect humans. Dr. Myron “Mike” Cohen, director of the UNC Institute for Global Health & Infectious Diseases is the...

Weiming Tang, PhD, promotes social innovations in health, using crowdsourcing that inspires the creation of equitable and effective health services, as well as pay-it-forward approaches that show how kindness can be contagious in healthcare. As co-director of Project China, Weiming has co-authored over 200 peer-reviewed publications. And when it comes...

Angela Wahl, PhD, a member of the Institute for Global Health & Infectious Diseases (IGHID), the International Center for the Advancement for Translational Science, and assistant professor in the division of infectious diseases has received a $3.2 million R01 award to study the role of microglia in HIV latency and...

Researchers from the HIV Prevention Trials Network (HPTN) presented updated results from the HPTN 084 long-acting cabotegravir (CAB) for pre-exposure prophylaxis (PrEP) study at the AIDS 2022 conference in Montreal. New findings show reductions in HIV incidence were sustained in the 12 months following trial unblinding (November 5, 2020, through...

Michael Sciaudone, MD, an infectious diseases specialist at UNC, has won a 2021 postdoctoral fellowship in tropical infectious diseases from the Burroughs Wellcome Fund-American Society of Tropical Medicine & Hygiene (ASTMH). Three of the coveted fellowships are awarded nationally each year, funding research focused on low and low-middle income countries....

The National Institutes of Health has awarded approximately $53 million in annual funding over the next five years to 10 research organizations in a continued effort to find a cure for HIV. The new awards for the Martin Delaney Collaboratories for HIV Cure Research program, initiated in 2011, further expand the...